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e-mail address: kmarfaj@gmail.com (K. AlArfaj).Khalid AlArfaj, MD a,b,⇑; Mohamed M. Hantera, Ph.D., FRCS, MBA cAbstractPurpose: We conducted a prospective study to determine the best treatment option for patients with low-to-moderate spherical
myopia or myopic astigmatism who are considered equally eligible for LASEK with mitomycin-C (MMC) and LASIK with either
mechanical microkeratome or femtosecond laser flap creation.
Methods: Forty-six adult patients (86 eyes) who underwent LASEK with MMC (16 patients, 31 eyes), and mechanical microkera-
tome LASIK (13 patients, 23 eyes) or Femtosecond LASIK (17 patients, 32 eyes) were assessed for clinical outcomes 1, 3 and
6 months post-operatively.
Results: Six months after surgery, all eyes in all three groups were within 1 D of the intended refractive change. UCVA 20/20 or
better was achieved in 96% of eyes undergoing LASEK with MMC 88% of eyes in the mechanical microkeratome LASIK and
72% of eyes in the Femtosecond LASIK group at 6 months. Mean spherical equivalent was 0.12 ± 0.22 D, 0.09 ± 0.28 D and
0.25 ± 0.28 D in the three groups, respectively (p = 0.077). Patients in the LASEK with MMC group had less high order
aberrations at 3 and 6 months compared to the two LASIK groups. None of the three procedures were associated with
early- or late-onset complications or loss of 2 or more lines after surgery.
Conclusions: After an initially slower visual improvement, LASEK with MMC, and to lesser extent, LASIK with mechanical microker-
atome, produced better visual acuity and less corneal aberrations compared to Femtosecond LASIK at 3 and 6 months after
surgery. These observations deserve further investigation in a randomized controlled trial.
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Laser in situ keratomileusis (LASIK) is the most popular
surgical procedure for the correction of myopia.1 However,
reports of post-LASIK ectasia have increased the interest
in surface-ablation techniques, such as photorefractive
keratectomy (PRK), laser-assisted subepithelial keratomileusis
(LASEK) and Epi-LASIK, which eliminate the need for a corneal
flap and aim to preserve a thicker stromal bed less prone tomechanical destabilization.2 LASEK is a relatively new
surgical procedure, in which certain elements of both LASIK
and PRK are combined, providing an improved benefit/risk
ratio. It is particularly valuable in patients with thin corneas
who would not qualify for LASIK surgery. The LASEK
procedure is known for long-term stable results and the lack
of serious complications, including infections, scars, recurrent
erosions, or late-onset corneal haze formation. Its major
disadvantages compared to LASIK surgery are considerede:
al.com
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ery until the epithelium heals.3 A more recent improvement
in LASIK flap creation has been the femtosecond laser photo-
disruption.4,5 Several randomized comparative studies
showed that femtosecond laser photodisruption produces
comparable or better visual outcome within 6 months after
the procedure and fewer complications compared to mechan-
ical microkeratomes,6–8 although no differences in clinical
outcomes at 12 months after keratomileusis were also
reported.9
The aim of this study was to determine the best treatment
option for patients with low-to-moderate spherical myopia or
myopic astigmatism by comparing the efficacy and safety of
three surgical procedures routinely performed at our center:
LASEK with mitomycin-C (MMC) 0.02%, mechanical micro-
keratome LASIK (MM LASIK), and LASIK with femtosecond la-
ser (Femtosecond LASIK). To the author’s best knowledge,
this is the first report of a formal comparison of these three
laser treatment modalities.Patients and methods
In this prospective, non-randomized study, 86 eyes of 46
patients (29 men, 17 women, mean age 27.8 ± 5.6 years) with
low-to-moderate myopia were treated with one of three laser
refractive procedures (LASEK with MMC, MM LASIK, or Fem-
tosecond LASIK), at the Magrabi Centre Dammam, Kingdom
of Saudi Arabia, between March and December 2009. The
study was conducted according to the principles of the
Declaration of Helsinki and approved by the local institutional
review board. All participants were informed about the risks
and benefits of the procedures and provided written
informed consent.
Patients were included if they were above 18 years of age,
had a confirmed low (0.50 to 3.00 D) or moderate myopia
(3.10 to 8.00 D), stable refraction for at least 12 months,
and had no known ocular or medical contraindications for
laser refractive surgery. Baseline characteristics of study
patients are provided in Table 1.Pre-operative assessments
Pre-operative assessments included a complete medical
and ophthalmological history and a thorough ocular exami-
nation, including uncorrected visual acuity (UCVA), manifestTable 1. Baseline patient characteristics.
LASEK + MMC group
Age, mean (SD), years 29.5 (5.3)
Gender, M/F 9 M/7 F
Number of eyes 31
UCVA 20/400 or worse, n (%) of eyes 12 (39%)
BSCVA 20/20, n (%) of eyes 28 (90%)
Manifest refraction, mean (SD), D
SEQ 2.60 (1.05)
Sphere 2.36 (1.12)
Cylinder 0.47 (0.61)
HOA, mean (SD), lm
Coma 0.15 (0.09)
Trefoil 0.26 (0.13)
Tetrafoil 0.09 (0.06)
Spherical 0.07 (0.05)
Abbreviations: D, diopter; F, female; HOA, high-order aberration; LASEK, laser epithelial
keratome; MMC, mitomycin-C; SD, standard deviation; SEQ, spherical equivalent.refraction, best spectacle-corrected visual acuity (BSCVA),
using a Snellen’s chart, central corneal thickness by ultrasonic
pachymetry (DGH Technology Inc., USA), and slitlamp biomi-
croscopic examination of both anterior and posterior seg-
ments. In addition, corneal topography, ocular wavefront
aberrations (HOA), autorefraction and pupil diameter mea-
surements were measured by Optical Path Difference scan
(OPD Scan II, Nidek Co., Ltd., Japan). Additional measure-
ments, including surface regularity index (SRI), area compen-
sated surface regularity index (SRC) and Strehl ratio were
obtained from the OPD station (Nidek Co. Ltd., Japan). SRI
is correlated to potential visual acuity and is a measure of lo-
cal fluctuations in central corneal power, whereas SRC is a
weighted form of the surface regularity index.
All treated eyes were considered suitable for vision correc-
tion using any of the three laser treatment modalities. After
they received a detailed explanation regarding the known
risks and benefits of the three treatment options, patients
were asked to decide about the method that they considered
most suitable. The selection was not guided or otherwise
influenced by the treating surgeon.Surgical procedures
All surgical procedures were performed by a single sur-
geon (M.M.H.). For patients in all three groups, who required
refractive surgery in both eyes, the selected procedure was
performed simultaneously, starting with the right eye and fol-
lowed by the left eye. Conventional excimer laser ablation
was performed using the Nidek platform (EC-5000 CXIII, Ni-
dek Co. Ltd.), with a mean optic zone (OZ) of 5.51 ± 0.61 mm
and mean transitional zone (TZ) of 8.14 ± 0.71 mm. The tar-
get in each case was full correction and pupil tracking was
used in all eyes. Astigmatism between 0.25 and 1.00 D was
treated with an attempted astigmatic correction.
The ocular surface pre-treated with moxifloxacin eye
drops (Vigamox, Alcon Laboratories Inc., USA) and anesthe-
tized with five drops of oxybuprocaine hydrochloride eye-
drops (Novesin, Novartis, Switzerland) administered at
five-minute intervals.LASEK with MMC 0.02% application
Thirty-one myopic eyes (15 right, 16 left) of 16 patients
underwent LASEK with the use of Nidek EC 5000 CXIIIMM LASIK group Femtosecond LASIK group
25.7 (3.9) 27.9 (6.6)
10 M/3 F 10 M/7 F
23 32
11 (48%) 18 (56%)
22 (96%) 26 (77%)
3.26 (1.25) 4.67 (2.34)
3.01 (1.24) 4.42 (2.27)
0.50 (0.43) 0.50 (0.38)
0.10 (0.06) 0.15 (0.14)
0.25 (0.15) 0.23 (0.20)
0.09 (0.24) 0.06 (0.05)
0.07 (0.05) 0.07 (0.05)
keratomileusis; LASIK, laser in situ keratomileusis; M, male; MM, mechanical micro-
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Inc., USA) was used to create epithelial dehiscence from the
underlying Bowman’s membrane. After 15 s of exposure of
the corneal epithelium to 20% ethanol (in distilled water),
ethanol was absorbed with a Merocel sponge (Medtronic
Solan, USA), and the cornea was thoroughly rinsed with
40 cc chilled balanced salt solution. The epithelial layer was
avulsed totally by a sharp Beaver blade (#69, Katena Products
Inc., USA). The laser was then applied to the stromal bed.
Mitomycin-C 0.02% was applied on the ablated stroma for
a duration depending on ablation depth (12 s if ablation
depth 6 75 l, 20 s if ablation depth 76–100 l), programming
an undercorrection of 10% of the intended spherical correc-
tion. Mean maximum ablation depth was 48.1 ± 19.1 lm
(range from 20.4 to 86.7 lm).
Mechanical microkeratome LASIK
In the second group of 13 patients, 23 eyes (12 right, 11
left) were treated with MM LASIK. Suction rings of Moria
M2 110 (Moria Inc., France) were used according to the man-
ufacturer’s nomogram to cut superiorly hinged 120 ± 19 lm
corneal flaps. The flap was lifted and ultrasonic pachymetry
of the central stromal bed was performed. Following laser
treatment, the flap was carefully repositioned. Mean maxi-
mum ablation depth was 61.8 ± 21.4 lm (range from 18.0
to 103. lm). For patients with both eyes undergoing the pro-
cedure, the same cut parameters and the same blade were
used for the fellow eye.
Femtosecond LASIK
In the third group, 32 myopic eyes (18 right, 14 left) of 17
patients underwent LASIK with flap created using a 60 kHz
femtosecond laser keratome (IntraLase™ FS60, Abbott Med-
ical Optics Inc., USA) with the following settings: attempted
flap depth of 100 lm, a 90 side cut, raster energy level of
1.70 mJ, and a side-cut energy of 1.90 mJ, (following the
manufacturer’s instructions). The laser was programmed to
achieve a superior hinge of 45 (corresponding to a hinge
length of 3.5 mm) and a flap diameter of 9.0 mm. Maximum
ablation depth averaged at 69.7 ± 26.9 lm (range from
19.8 to 112.0 lm) and the actual flap thickness was
114 ± 12 lm.
Post-operative care and follow-up
At the conclusion of the procedure, tobramycin 0.3% and
dexamethazone 0.1% (TobraDex, Alcon Laboratories Inc.,
USA) eye drops were administered 4 times a day. All LASEK
patients were fitted with soft bandage contact lens (Acuvue
Oasys, Johnson & Johnson Vision Care Inc., USA) at the end
of the procedure and removed after complete epithelization,
usually at 4th day postoperatively. Patients were instructed to
immediately start using preservative-free lubricating eye
drops (Tears Naturale Free, Alcon Laboratories Inc., USA)
every hour for three months postoperatively. Post-operative
pain was managed with oral diclofenac 100 mg (Voltaren-
XR, Novartis, Switzerland).
Post-operative assessments were completed 1, 3 and
6 months after the refractive surgery. Clinical outcomes of
interest were distant UVCA to 6 months, changes in HOAs,predictability, stability, and Strehl ratio between the three
groups.
Data collection and statistical analysis
Clinical outcome data were collected pre- and 1, 3 and
6 months after refractive surgery and entered in an
Excel-based database. The following variables were assessed
at 1, 3 and 6 months post-surgery and compared to
pre-operative values: UCVA, manifest refraction, BSCVA,
HOA, Strehl ratio, SRI and SRC. For the purposes of statistical
comparisons, visual acuity measurements (UCVA, BSCVA)
were converted to logarithm of the minimum angle of resolu-
tion (LogMAR) units, using a Snellen-LogMAR Visual Acuity
Calculator. Ocular aberrations were evaluated by analyzing
the root mean square (RMS) of high order aberrations for
6 mm pupil diameters at 1, 3 and 6 months post-surgery.
One-way analysis of variance (ANOVA) was used to compare
the groups in terms of the achieved spherical equivalent
(SEQ) correction at each postoperative assessment as well
as the 6-month UCVA, BSCVA and HOA. Stability of the
achieved spherical equivalent (SEQ) correction was monitored
over the 6-month follow-up period and presented graphically,
using Datagraph Software 4.0. Predictability of SEQ was
evaluated by comparing the attempt to achieved SEQ at the
end of the 6-month follow-up period. Unless otherwise
indicated, data are expressed as mean (SD). Differences were
considered to be statistically significant when P < .05.Results
All 46 patients who underwent refractive surgery had a
minimum of 3 months follow-up. Three patients (6 eyes) in
the LASEK with MMC group and four patients (7 eyes) in
the MM LASIK group did not return for their 6-month fol-
low-up due to relocation from the Eastern Province of Saudi
Arabia.
Efficacy
Three months after surgery, UCVA was 20/20 or better in
28 eyes (90%) of the LASEK with MMC group, 20 eyes (87%)
of the MM LASIK group and 16 eyes (50%) of the Femtosec-
ond LASIK group. Based on patients with a complete
6-month follow-up, UCVA was 20/20 or better in 96%, 88%
and 72% of the treated eyes in the three groups, respectively
at 6 months. Importantly, an UVCA of 20/15 or better was
achieved in 56% of the eyes undergoing LASEK with MMC,
25% undergoing MM LASIK and none of the Femtosecond
LASIK group 6 months after surgery (see Table 2). The be-
tween-group differences in UCVA and BSCVA were statisti-
cally and clinically significant in favor of the LASEK with
MMC group (see Table 3).
One month after surgery, SEQ averaged 0.14 ± 0.63 D in
the LASEK plus MMC group,0.07 D ± 0.38 D in the MM LA-
SIK group and 0.43 D ± 0.37 D in the Femtosecond LASIK
group; p = 0.012. Importantly, the achieved corrections were
maintained throughout the follow-up, with the between-
group differences remaining statistically significant at
3 months post-procedure (0.19 ± 0.34 D, 0.04 D ± 0.52 D
and 0.43 D ± 0.47 D, respectively; p = 0.012), but not at
the end of the 6-month follow-up period (0.12 ± 0.22 D,
Table 2. Postoperative uncorrected visual acuity in the three treatment groups.
UCVAa LASEK + MMC group MM LASIK group Femtosecond LASIK group
1 mo n = 31 3 mo n = 31 6 mo n = 25 1 mo n = 23 3 mo n = 23 6 mo n = 16 1 mo n = 32 3 mo n = 32 6 mo n = 32
20/15 or better 0 0 14 (56) 2 (9) 4 (17) 4 (25) 0 0 0
20/20 or better 13 (42) 28 (90) 24 (96) 16 (70) 20 (87) 14 (88) 27 (84) 16 (50) 23 (72)
20/25 or better 25 (81) 25 (81) 25 (100) 18 (78) 22 (96) 16 (100) 30 (94) 25 (78) 29 (91)
Abbreviations: LASEK, laser epithelial keratomileusis; LASIK, laser in situ keratomileusis; MM, mechanical microkeratome; MMC, mitomycin-C; n, number of eyes; UCVA,
uncorrected visual acuity.
a Results are presented as number (%) of eyes examined at the specified follow-up visits.
Figure 1. Stability of the achieved correction (spherical equivalent) over
6 months of follow-up.
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p = 0.077); see Fig 1. All eyes in all three groups were within
1 D of the intended refractive change at 6 months. In
addition, 22 out of 25 eyes (88%) in the LASEK, 15 out of
16 eyes (94%) in the MM LASIK and 30 out of 32 eyes
(94%) in the Femtosecond LASIK group were within 0.5 D
of the target refractive correction (see Fig 2). The LASEK with
MMC group had fewer high order aberrations compared to
two other groups, including a significantly lower occurrence
of coma aberrations at the end of the 6-month follow-up
(see Table 3).
Conversely, six months after refractive surgery, quality of
vision, assessed by the Strehl ratio was comparable to pre-
operative values in the two LASIK groups, whereas it in-
creased from 0.07 to 0.20 in the LASEK with MMC group
(see Fig 4).
Safety
None of the procedures were associated with early- or
late-onset complications, including diffuse lamellar keratitis,
infections or interface haze or fibrosis at 1, 3 or 6 months post
surgery (see fig 3).
The safety of the three procedures was also evaluated by
the number of lines lost or gained after surgery. Six months
after refractive surgery, all eyes (100%) treated with LASEK
with MMC, 93% of the eyes undergoing MM LASIK and
77% of the eyes undergoing Femtosecond LASIK surgery
had an unchanged BSCVA. There was a gain of 1 line in
19% of eyes treated with Femtosecond LASIK, whereas the
remaining 7% of eyes in the MM LASIK group and 3% of
the eyes in the Femtosecond LASIK group showed a loss of
1 line after surgery.
Discussion
The objective of this prospective study was to determine
the best treatment option for patients with low-to-moderate
spherical myopia or myopic astigmatism who were consid-
ered equally eligible for LASEK with MMC, MM LASIK, and
Femtosecond LASIK procedures. Our data indicate that both
LASEK with MMC and MM LASIK may produce comparable
or better as well as more stable visual acuity and comparable
or less high order aberrations compared to the Femtosecond
LASIK group at 6 months after surgery. Patients in the Femto-
second group achieved a relatively faster visual rehabilitation
(UCVA was 20/20 or better in 84% of patients) compared to
MM LASIK or LASEK with MMC (70% and 42%, respectively)
during the first post-operative month. However, this initial
Figure 2. Attempted vs. achieved correction of spherical equivalent
(SEQ; predictability) at 6 months after refractive surgery.
Table 3. Summary of 6 month post-operative data.
LASEK +
MMC
Group
MM
LASIK
group
Femto
LASIK
group
P-valuea
Number of eyes 25/31 16/23 32/32 –
UCVAb, mean
(SD)
0.07
(0.06)
0.02 (0.07) 0.04 (0.07) <0.0001
BSCVAb, mean
(SD)
0.02
(0.05)
0.01 (0.03) 0.00 (0.02) 0.012
Manifest refraction, D
SEQ, mean (SD)
Range
0.12
(0.22)
[0.50,
0.25]
0.09 D
(0.28)
[-0.50, 0.50]
0.25
(0.28)
[1.25,
0.00]
0.012
HOA, mean (SD), lm
Coma 0.08 (0.05) 0.15 (0.06) 0.16 (0.09) 0.001
Trefoil 0.14 (0.07) 0.15 (0.06) 0.17 (0.12) 0.423
Tetrafoil 0.04 (0.03) 0.06 (0.04) 0.06 (0.04) 0.097
Spherical 0.04 (0.03) 0.05 (0.04) 0.05 (0.04) 0.193
Abbreviations: D, diopter; HOA, high-order aberration; LASEK, laser epithelial ker-
atomileusis; LASIK, laser in situ keratomileusis; MM, mechanical microkeratome; SD,
standard deviation; SEQ, spherical equivalent.
a P-value: between-group comparison based on single-factor ANOVA.
b LogMAR units.
Figure 3. Mean root mean square of high order aberrations over
6-months of follow-up.
Figure 4. Strehl ratio over 6-months of follow-up.
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half of the Femtosecond LASIK group compared to approxi-
mately 90% in the LASEK with MMC and MM LASIK groups),
and 6 months after the procedure (UCVA was 20/20 in 78%,
96%, and 88% of the patients in the three groups,
respectively). In terms of the stability of spherical equivalent
over time, best correction was achieved in patients undergo-ing MM LASIK, followed by the LASEK with MMC and
Femtosecond LASIK groups. At the end of the 6-month
follow-up period, all three procedures have achieved
what was intended in more than 95% of cases, indicating
comparable predictability.
For a 6-mm pupil, there was a temporary increase in the
HOA RMSs in all three groups during the first 3 months after
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ues by 6 months with a non wavefront guided ablation pro-
file. In our study the amount of high order aberrations was
higher in patients undergoing Femtosecond LASIK compared
to MM LASIK or LASEK with MMC (HOA RMS 0.29, 0.23 and
0.19, respectively) at 6 months. These results challenge the
findings of earlier reports8–10 showing less high order aberra-
tions with flap creation using Femtosecond LASIK compared
to mechanical microkeratome LASIK, whereas they are con-
sistent with several recently published studies that failed to
demonstrate better visual outcomes11–15 and less high order
aberrations11–15 with Femtosecond compared to MM LASIK.
Changes in the optics of the eye induced by corneal
refractive surgery are well reflected by the Strehl intensity ra-
tio. The Strehl ratio is considered useful for the qualitative
assessment of the retinal image and for quantifying optical
degradation imposed by different optical conditions.16 In
the current study, the Strehl ratio was higher for the LA-
SEK-treated eyes compared to eyes undergoing either of
the LASIK procedures 6 months post-surgery.
Several previous clinical trials found that LASEK and LASIK
produce similar visual outcomes when used for the correction
of low and/or moderate myopia.17–19 However, to our knowl-
edge, the current study is the first to compare clinical out-
comes between patients undergoing LASIK with either
mechanical microkeratome or femtosecond laser and pa-
tients treated with LASEK.
The observations from our study have several weaknesses.
The non-randomized method of treatment allocation re-
sulted in a small imbalance in the number of patients and in
some baseline patient characteristics between the three
groups. Notably, the degree of pre-operative myopia was
slightly higher in the Femtosecond LASIK group compared
to the other two groups. Selection bias was at least partially
offset by having each patient select one of the three laser
refractory procedures, however it could not be completely
ruled out. Due to a disproportion in the number of patients
lost to follow up, the withdrawal rate varied between 0% in
the Femtosecond LASIK and 31% in the MM LASIK group.
Lastly, despite the good visual and refractive results ob-
served in our patients, the study follow-up was limited to
six months, which does not rule out the possibility of subse-
quent regression.
In summary, consistent with previous reports, all three pro-
cedures can be considered adequate for the correction of
myopia. However the results of the current study indicate
that, after an initially slower visual improvement, LASEK with
MMC, and to a lesser extent, LASIK with mechanical micro-
keratome, may produce comparable or better visual acuity
and comparable or less high order aberrations compared
to Femtosecond LASIK at 3 and 6 months after surgery.
These observations deserve further investigation in an ade-
quately controlled, randomized trial.
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